Uppsala Monitoring Centre

23/01/2026

Underreporting in remains a persistent global challenge.

Historical data suggest that only 2–4% of non-serious and around 10% of serious adverse events are reported each year. With factors such as reporter behaviours and attitudes, limited knowledge, complex procedures, the accessibility of reporting systems, and social and cultural barriers all contributing to its persistence, 𝙝𝙤𝙬 𝙘𝙤𝙪𝙡𝙙 𝙬𝙚 𝙙𝙤 𝙗𝙚𝙩𝙩𝙚𝙧?

In the latest print issue of , we explore how a multi-modal approach is essential to breaking down barriers and addressing the complex web of factors driving underreporting today.

Read more 👉 https://ow.ly/kEv050XSTmK

22/01/2026

𝘋𝘪𝘥 𝘺𝘰𝘶 𝘬𝘯𝘰𝘸? Medication errors aren't limited to just medicines. They can occur in these areas as well:

💉 Vaccines
🩸 Medical devices
💊 Supplements
🩺 Diagnostics

We go beyond medicines in the photos below👇 and into the scope of , those most at risk, and how we can prevent them in our interactive deep dive.

Read for the full picture 👉 https://ow.ly/F4q150W5qYF

20/01/2026

🎥 At the heart of Brazil🇧🇷's pharmacovigilance system since 2018, has combined national oversight with decentralised reporting to strengthen the safety surveillance of medicines and vaccines.

UMC has worked closely with Anvisa to provide the tools and training to enhance the national pharmacovigilance system, helping regional PV centres and healthcare facilities improve adverse event reporting, monitoring, and case management at the district level.

In the latest film in our 'WHO PIDM in Focus' series, we hear from local stakeholders, including Anvisa, regional PV centres, hospitals, and specialist healthcare providers, about how they are utilising the key features of VigiFlow to collaborate in multidisciplinary teams, improve communication, implement safeguards, and, above all, foster a culture of .

Watch the film below👇 to learn more, and explore the rest of the series on YouTube 👉 ow.ly/j81o50QPVtJ

Hospital Regional de Santa Maria DF Hospital Da Criança De Brasília José Alencar InCor - Instituto do Coração do HCFMUSP

20/01/2026

Abstract submission and registration are now open for the International Pharmaceutical Federation (FIP) World Congress in Montreal, Canada 🇨🇦

📆 30 August – 2 September 2026
❗️ The deadline to submit your abstract is 18 March 2026

Learn more about the event and how you can register in the post below 👇

Exciting news! Registration and abstract submission are now open for the 84th FIP World Congress of Pharmacy and Pharmaceutical Sciences, taking place in Montreal, Canada from 30 August to 2 September 2026. Submit your abstract by 18 March here (https://montreal2026.fip.org/programme/call-for-abstracts/) and register by 3 June here (https://montreal2026.fip.org/registration-fees/) to secure the special early bird fee. The congress is open to all and offers an exciting opportunity to celebrate the pharmacy profession in person.

19/01/2026

📚 New release — Version 9 of the Glossary of ICH Terms and definitions is now available. The glossary includes terms and definitions in the guidelines of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). Download your copy at the link below👇

Version 9, 9th December 2025 -- This glossary combines the terms and definitions included in the guidelines of the International Council for Harmonisation

16/01/2026

Next month, the first ISoP Online European Artificial Intelligence seminar kicks off in Basel, Switzerland🇨🇭. UMC's Niklas Norén and Eva-Lisa Meldau will be in attendance to discuss emerging technologies and human expertise in , including trusted use of AI, case processing, and .

Join Niklas on:
📆 Monday, 16 February 2026
🕟 16:30 CET

Join Eva-Lisa on:
📆 Tuesday, 17 February 2026
🕘 09:00 & 11:00 CET

Learn more about and register today 👉 https://ow.ly/15gq50XWGFX

15/01/2026

Some of us are more vulnerable to , particularly if we are elderly, children, or pregnant.

As we age, we often rely on medications to manage our health. , physical impairment, and adherence to complicated medication regimens may contribute to increased risk for medication errors in elderly patients.

Learn more about each factor in the images below👇 and read our interactive for the full picture 👉 https://ow.ly/F4q150W5qYF

14/01/2026

Are you attending DrugInfoAssn's Regulatory Submissions, Information, and Document Management Forum in North Bethesda, MD🇺🇸?

Join UMC's Magnus Wallberg for a session that will explore implementing global identifiers and FHIR for smarter :

📆 Tuesday, 3 February 2026
🕐 13:15–14:30 EST
📍 Bethesda North Marriott Hotel and Conference Center

Learn more about the session and the conference here 👉 https://ow.ly/18jE50XVWCc

13/01/2026

Mitul Jadeja at the UK's Medicines & Healthcare products Regulatory Agency played a key role in establishing from its predecessor and shaping it into the successful global campaign it is today. He shares his expertise on campaign management, stakeholder collaboration, and compounding on yearly objectives to set your campaign up for success in .

Read the print issue today 👉 https://ow.ly/h3Co50XTYIS

12/01/2026

🎧 Catch up on recent episodes and stay informed about some of the most pressing issues in the world of medicines safety. Our latest episodes explore:

🌐 The WHO Global Smart PV Strategy – Shanthi Pal
🤖 Artificial intelligence in PV, part 1 and 2 – Niklas Norén
👧🏻 Paediatric pharmacovigilance – Angela Caro-Rojas

Tune in today 👉 https://www.drugsafetymatterspod.org

09/01/2026

What is your vision for ?

First-time participants Vietnam🇻🇳 and Mozambique🇲🇿 tell us why they decided to join the campaign and where they envision their pharmacovigilance communications initiatives heading in the future.

Read the latest print issue of for more 👉 https://ow.ly/FttZ50XTVG5

08/01/2026

🌍 How is shaping pharmacovigilance across the WHO Programme for International Drug Monitoring (PIDM)?

We spoke to Manal Younus (Iraqi PV Center) and Jaber Jaber (Jordan FDA) to hear how they're utilising VigiFlow and connected applications to monitor the safety of medicines and vaccines.

From easing communication between national and regional PV centres, to streamlining reporting procedures, supporting evidence-based decision-making and risk minimisation activities, VigiFlow is the building block for a robust pharmacovigilance system.

🎥 Watch the video below to hear more from Manal and Jaber👇